MadeMed sells a short menu of compounded wellness products — sermorelin, NAD+ as an injection or a nasal spray, glutathione, GHK-Cu — alongside GLP-1s and a sexual-health troche, each on three plan lengths. Most of its product pages print the concentration beside the price, which is less common in this market than it should be.

What changed in October

The site was rebuilt in October 2026. Every product moved to a new address, the old pages now answer “not found”, and the price structure changed with them.

On our August read, sermorelin was $169 a month on a six-month plan, $179 on three months, and the page printed the vial: 9mg/3mL, a 30-day supply. On 23 October the six-month plan is gone, the rates are $179 every 30 days, $161 a month on 90 days and $143 on 360 days — and the page names the active ingredient without any strength at all. NAD+ fell further: $199 a month in August, $149 to $119 now. Oral sermorelin is no longer on the menu; glutathione and a GHK-Cu scalp solution are new.

The price and what it buys

Where the strength is published, it sits on the same page as the price. NAD+ injection: 200 mg/mL, typically two injections a week, $149 to $119 a month. The nasal spray: 300 mg/mL, once a day, $129 to $103. Glutathione: 200 mg/mL, $89 to $71. GHK-Cu for the scalp: 3%, $199 month to month and $189 on either longer plan.

Sermorelin is the exception, and it is the product most people come here for. A monthly price without a dose is not comparable to anything; until the page prints the strength again, ask for it before you pay.

The catch is the term, not the teaser

There is no first-month promotion here, which is worth saying plainly because half this market runs on them. What there is instead: the advertised “from” rate is the longest commitment. $143 sermorelin means handing over $1,718 today. Ninety days costs $161 a month, paid as $483. Month to month is $179.

That is a different shape of catch and, on balance, an honester one — you can see exactly what you are committing to before you commit. But the $143 rate also comes with the biggest single charge, $1,718 up front, and that inversion catches people out.

Separately, the injectables are lab-gated. Sermorelin needs an IGF-1 result, NAD+ needs a CMP, and you arrange and pay for the test yourself. The plan table also lists a $20 consultation fee, $30 for a video visit. Nowhere on the site is the lab cost estimated.

One page we will not repeat

MadeMed sells a sublingual troche combining tadalafil, PT-141 and oxytocin, under the name Mood Drive. Its page states that PT-141 is FDA-approved for low sexual desire.

Bremelanotide is approved — as Vyleesi, a subcutaneous autoinjector, for acquired generalised hypoactive sexual desire disorder in premenopausal women. The product being sold is a compounded troche. It is approved for nothing, and compounded drugs are by definition not FDA-approved.

So this catalogue does not list MadeMed as a seller of PT-141 or oxytocin and carries no price for that troche. One thing has improved since August: the page now prints all three doses — tadalafil 20 mg, PT-141 1 mg, oxytocin 20 IU — where it used to quantify only the tadalafil.

Seven years of domain, months of peptides

The registration date says August 2019, and that is worth reading carefully, because it is the domain’s age rather than the company’s.

The Wayback Machine’s first capture of this address, in December 2021, is a redirect to a dan.com listing offering mademed.com for sale — two years after registration, it was parked. Between then and last summer the archive holds essentially nothing.

The July 2025 capture is a real, live site. It sells oral GLP-1 for weight loss, and only that: no sermorelin, no NAD+, no troche, no peptide of any kind anywhere on the page. Everything this catalogue lists them for arrived after that date.

Which answers a question their pages otherwise raise. A seven-year-old company with no Trustpilot profile and no BBB record would be strange. A peptide business a few months old with neither is ordinary. Being new is not a mark against them — but it is the context the pricing above sits in, and it is not something the site itself tells you.

Who is behind it

The operating company is IDL Health LLC. Since the rebuild, the terms name MDI Medical Group PC as the medical group and four partner pharmacies — Absolute RX, Strive Pharmacy, ERX Hub and Southend Pharmacy — without saying which fills which prescription. In August the same terms named a different medical group, and the about page named a physician and a fifth pharmacy; neither is there now. No street address appears anywhere on the site.

Here is every plan they publish, what the price covers, and what it does not.